UPC Court of Appeal tackles broad functional antibody claims (UPC_CoA_529/2024) By Dr Rose Hughes on Monday, December 01, 2025 antibody inventions inventive step patents PatKat Rose Hughes sufficiency upc +
Insufficiency resulting from mutually exclusive definitions: The repercussive effect of dependent claims (T 0878/23) By Dr Rose Hughes on Friday, November 07, 2025 claim intepretation epo G1/24 patents PatKat Rose Hughes sufficiency +
Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23) By Dr Rose Hughes on Wednesday, October 22, 2025 antibody inventions epo functional claim language patents PatKat plausibility Rose Hughes sufficiency +
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 By Annsley Merelle Ward on Friday, May 09, 2025 #IPKat AstraZeneca epc G 2/21 Michael Tappin QC patent litigation plausibility SPC sufficiency Teva UK +
The plausibility of diagnostic inventions: No data, no patent (T 0589/22) By Dr Rose Hughes on Tuesday, April 29, 2025 diagnostic methods epo G2/21 patents PatKat plausibility post-published data Rose Hughes sufficiency +
To infinity and beyond! The sufficiency requirements for open-ended ranges (T 1977/22) By Dr Rose Hughes on Tuesday, March 04, 2025 epo patents PatKat ranges Rose Hughes selection inventions sub-ranges sufficiency +
Epitope claims stand firm: Board of Appeal upholds functional antibody patent despite insufficiency attack (T 0326/22) By Dr Rose Hughes on Sunday, January 19, 2025 antibodies Board of Appeal epo inventive step PatKat Rose Hughes sufficiency +
Fishy evidence: Do we have the right sufficiency standard for therapeutic use? (T 1057/22) By Dr Rose Hughes on Tuesday, August 06, 2024 epo insufficiency patents PatKat plausibility Rose Hughes sufficiency +